Estimating rare disease prevalence and costs in the USA: a cohort study approach using the Healthcare Cost Institute claims data
Objective The study capitalised on national insurance claims data to gather information on patient characteristics and associated costs to better understand the diagnosis and treatment of rare diseases (RDs).Materials and methods Data from the Healthcare Cost Institute (HCCI) data enclave were analy...
Saved in:
Main Authors: | Keith A Crandall, Christine M Cutillo, Ainslie Tisdale, Mahdi Baghbanzadeh, Reva L Stidd, Manpreet S Khural, Laurie J Hartman, Jeff Greenberg, Kevin B Zhang, Ali Rahnavard |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-04-01
|
Series: | BMJ Public Health |
Online Access: | https://bmjpublichealth.bmj.com/content/2/1/e000346.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implications for cost and access of site-of-service referrals for ancillary medical services in a US Medicaid population: analysis of claims data from Maryland, USA
by: Maqbool Dada, et al.
Published: (2022-06-01) -
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
by: Anas S. Tresh, et al.
Published: (2025-01-01) -
Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis
by: Katharina Schley, et al.
Published: (2024-11-01) -
Glycogen Storage Disease Type Ia: A Retrospective Claims Analysis of Complications, Resource Utilization, and Cost of Care
by: Eliza Kruger, et al.
Published: (2025-01-01) -
Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
by: Sue Perera, et al.
Published: (2018-02-01)